In 1872 Duplay described a condition,
patients. The presence of shoulder capsulitis, Dupuytren disease, and limited joint mobility was sought. The patients were assessed for background and proliferative retinopathy, nephropathy, autonomic neuropathy, and peripheral symmetrical somatic polyneuropathy. Diseases closely related to diabetes (hypertension, history of myocardial infarction, coronary heart disease, and peripheral vascular disease) were also recorded. Results-Prevalence of shoulder capsulitis was 10 .3% in type I and 22.4% in type II diabetic subjects. Shoulder capsulitis was associated with the age in types I (P < 0.01) and II (P < 0.05) diabetic patients, and with the duration of diabetes in type I patients (P < 0.01). Odds ratios for autonomic neuropathy in type I and type II diabetic subjects with shoulder capsulitis were 4.1 (95% confidence interval, 1.6 to 10.9) and 2.7 (95% CI, 1.1 to 7.0), respectively, after controlling for age and duration of diabetes. Odds ratio for history of myocardial infarction in type I diabetic subjects with shoulder capsulitis was 13.7 (95% CI, 1.3 to 139.5) after controlling for age, duration of diabetes, hypertension, and smoking habits. Other associations between shoulder capsulitis and diabetic complications, related diseases, and other hand abnormalities were fully explained by age and the duration of diabetes. Conclusions-Shoulder capsulitis is common in type I and type H diabetic patients. It is associated with age in type I and II diabetic patients and with the duration of diabetes in type I patients. It is associated with autonomic neuropathy in type I and II diabetic patients and with history of myocardial infarction in type I diabetic patients, independently of time related variables.
(Ann Rheum Dis 1996;55:907-914)
In 1872 Duplay described a condition, "peri-arthrite scapulo-humerale", which differed from arthritis in its symptoms and clinical course.' The true nature of this condition has been discussed ever since. Duplay himself believed that a subacromial bursitis was the basic cause of the pain and dysfunction. By 1916 Klapp and Riedel believed that the joint capsule was affected, and later, in 1931, Payr tried to reduce distension of the retracted capsular tissue by intra-articular injections (citation by Lund- berg'). In 1934 Codman showed that stiffness and pain in the shoulder could occur without noticeable exogenous influences and he termed the condition "frozen shoulder", which has later been used as a synonym for humeroscapular periarthritis and adhesive capsulitis of shoulder (shoulder capsulitis).' Codman believed that shoulder capsulitis was caused by tendinitis in the short rotators, but more recently the thickening of the joint capsule and its adherence to the head of the humerus resulting in marked reduction in the volume of the glenohumeral joint have been considered as the basic pathological change in shoulder capsulitis. 4 The aetiology of shoulder capsulitis is not clearly understood. Attempts have been made to relate it to various circumstances such as inactivity, strain, and pre-existing shoulder disorders, for example trauma.5 Several conditions have been associated with shoulder capsulitis; these include cervical spondylosis,6 coronary heart disease,78 hemiplegia,9 pulmonary tuberculosis,'0 bronchial carcinoma," hyperthyroidism,," cerebral tumour, and epilepsy. ' Bilateral involvement of shoulder capsulitis was more common in diabetic (10%) than in mobility, has been found among diabetic patients with shoulder capsulitis."8l9 The association between limited joint mobility and microvascular complications of diabetes has been well documented, but there are also two studies showing an association between shoulder capsulitis and retinopathy. '9-22 However, no association between shoulder capsulitis and diabetic neuropathy has been found. '4 The purpose of this study was to investigate the prevalence of shoulder capsulitis and its association to the diabetic complications in type I and II diabetic subjects.
Methods

PATIENTS
We evaluated 425 Finnish diabetic patients (200 men and 225 women) attending the departments of medicine in Turku University Central Hospital (n = 111) and Paijat-Hame Central Hospital (n = 57) in Lahti, in a private diabetes outpatient clinic in Turku (n = 217), and in the municipal health centre of Turku (n = 40). Of these, 291 had type I and 134 type II diabetes according to the classification of the National Diabetes Data Group. 23 Patients were considered to have type II diabetes if there was no previous history of ketoacidosis and they had not suffered from severe weight loss. All the insulin treated patients in the type II diabetes group were over 50 years at the time of the diagnosis of diabetes, or their fasting plasma C peptide value was over 0.3 nmol litre-', or the stimulated plasma C peptide value was over 0.7 nmol litre'1.
CLINICAL EXAMINATION
The criteria for shoulder capsulitis, previously described by Pal et al, were shoulder pain for at least one month, an inability to lie on the affected shoulder, and restricted active and passive shoulder joint movements in at least three planes. ' The symptoms of somatic peripheral symmetrical polyneuropathy included pain, paraesthesiae, and muscle weakness. Knee and ankle jerks and vibration sense over the lateral malleoli and over the styloid processes of radii (using a 256 Hz tuning fork) were tested. The patients were considered to have peripheral symmetrical somatic polyneuropathy if they had typical symptoms and impaired vibration sense, or if both ankle jerks were absent. The diagnosis of autonomic neuropathy was based on structured questions regarding anhidrosis or hyperhidrosis of the extremities or body, or a gustatory sweating disorder. Heart rate variation was assessed in 121 subjects by measuring the standard deviation of R-R intervals in the supine position'5 and by calculating the difference between the maximum and minimum heart rates during deep breathing, as described elsewhere.'6 The diagnosis of postural hypotension was based on a structured question regarding symptoms of hypotension on stand up.
Blood pressure was measured sitting after a period of rest of at least 10 minutes using a standard mercury sphygmomanometer. The reading when the fifth Korotkoff sound disappeared was taken as the diastolic blood pressure. Subjects were defined as having hypertension if they used antihypertensive drugs for hypertension or had a systolic blood pressure of . 160 mm Hg or a diastolic blood pressure of 2 95 mm Hg.
The subjects' smoking history was recorded. An ex-smoker was defined as a person having smoked regularly at any time in the past.
A history of myocardial infarction was based on symptoms of chest pain, electrocardiogram (ECG) abnormalities, and enzyme determinations. The criteria for coronary heart disease were a history of definite myocardial infarction or ischaemic ECG abnormalities during angina pectoris type chest pain at rest or during an exercise test. Peripheral vascular disease was present if one or two tibialis posterior pulses were absent. BMI, body mass index; GHbA,C, glycated haemoglobin. * P < 0.01 compared to the patients without shoulder capsulitis (ANOVA). (table 4) . The prevalence of a history of myocardial infarction was 2% and 19% and of coronary heart disease, 7% and 41% in type I and II diabetic subjects, respectively. Both type I and type II diabetic subjects with myocardial infarction had shoulder capsulitis more often than those without myocardial infarction, whereas an association between coronary heart disease and shoulder capsulitis was found only in type I diabetic subjects (tables 3 and 4). Because myocardial infarction was strongly associated with the duration of diabetes and age, we used stepwise logistic regression analysis to control the confounding effect of these time related variables. Smoking habits and hypertension were also included in the model. The odds ratio for myocardial infarction in type I diabetic subjects was 13.7 (95% CI, 1.3 to 139.5) when the confounding effects of the age, the duration of diabetes, hypertension, and smoking habits were controlled. The correlation remained significant when serum total cholesterol was included in the model. In type II diabetic subjects no correlation was found between shoulder capsulitis and myocardial infarction when the time related variables were controlled for. No association between shoulder capsulitis and coronary heart disease was found when the confounding effects of the duration of diabetes or the age were controlled for in type I or II diabetic subjects.
The prevalence of peripheral vascular disease was 13% and 26% in type I and II diabetic patients, respectively. Type I diabetic patients with peripheral vascular disease had shoulder capsulitis more often than those without peripheral vascular disease (P < 0.01) (table 3), but this association was fully explained by the age and the duration of diabetes. No association was found between peripheral vascular disease and shoulder capsulitis in type II diabetic subjects (table 4) .
LIMITED JOINT MOBILITY AND DUPUYTREN DISEASE
The prevalence of limited joint mobility was 60% in type I and II diabetic patients. No association between limited joint mobility and shoulder capsulitis was found in type I diabetic subjects (table 3) . Type II diabetic subjects with limited joint mobility had shoulder capsulitis more often than those without (table 4), but this association disappeared when the confounding effects of the duration of diabetes and the age were controlled for.
The prevalence of Dupuytren disease was 14% in both type I and II diabetic subjects. Twenty five per cent of type I diabetic subjects with Dupuytren disease had shoulder capsulitis compared to 8% without Dupuytren disease (P < 0.01). This association disappeared when the confounding effects of time related variables were controlled for. No significant association between Dupuytren disease and shoulder capsulitis was found in type II diabetic subjects (table 4) .
Discussion
This report shows that shoulder capsulitis is a common disorder in both type I and type II diabetic subjects, which is in line with previous studies.' 4 18 21 The presence of shoulder capsulitis was highly dependent on the age and the duration of diabetes in type I diabetic subjects, whereas age was the most important factor explaining shoulder capsulitis in type II diabetic subjects. The prevalence of shoulder capsulitis increased after the age of 40 and 50 years in type I and II diabetic patients, respectively. The prevalence of shoulder capsulitis did not increase until after the duration of diabetes had exceeded 20 years in type I diabetic patients. The reason for the high prevalence of shoulder capsulitis after a short duration of diabetes in type II patients may be explained by the fact that the known duration of diabetes is probably an inaccurate marker of the true duration of the disease in many patients with type II diabetes. Two previous studies have shown an association between shoulder capsulitis and the duration of diabetes,"62' but these studies showed no association between shoulder capsulitis and the age of diabetic subjects. Sattar and Luqman have shown no difference in the prevalence of shoulder capsulitis in insulin treated and non-insulin-treated diabetic subjects.2' The higher prevalence of shoulder capsulitis in type II diabetic subjects seen in our study was most probably explained by the higher age of these subjects compared to type I patients. In addition to the different age and the duration of diabetes, type II diabetic subjects differed from type I in that they had a higher BMI, which is, however, unlikely to explain higher prevalence of shoulder capsulitis because no association was found between shoulder capsulitis and BMI.
Smoking has been shown to contribute to microvascular complications in diabetic subjects."0 Eadington et al found that smoking associated with limited joint mobility but not with Dupuytren disease,3' whereas Gamsted et al found no association between smoking and these hand abnormalities."2 In the present study, shoulder capsulitis was associated with previous smoking in type I subjects, but this association was fully explained by the fact that subjects who had previously smoked were older than non-smokers or present smokers. Shoulder capsulitis was associated with present smoking in type II diabetic subjects and this was not explained by the age of the patients, by the duration of diabetes, or by the control of diabetes. The association may be explained by the fact that smoking causes vasoconstriction, which may also underlie the development of shoulder capsulitis.
Recently a strong relation between long term glycaemic control and diabetic microvascular complications has been definitely established. 33 It would be important to know if other diseases closely related to diabetes are also related to the long term glycaemic control. Bridgman investigated 800 diabetic patients (23% of them were insulin dependent) and he stated that shoulder capsulitis correlated with the severity of diabetes because 36% of the affected (shoulder capsulitis) patients were insulin dependent.'4 Mavrikakis et al have also stated that shoulder capsulitis is associated with the poor control of diabetes, because type II diabetic subjects who had shoulder capsulitis were more often insulin treated than those without shoulder capsulitis.'6 We found no difference in the prevalence of shoulder capsulitis in type II diabetic subjects treated with different regimens. According to present knowledge the type of regimen is not good marker of the control or severity of diabetes. In the present study, type II diabetic patients with poor control of diabetes (GHbA1C > 9%) seemed to have more shoulder capsulitis than patients with better control (figure). However, no significant association between shoulder capsulitis and the control of diabetes was found in type I or II diabetic patients. The reason for not finding a significant association might be that there were very few patients whose control was as good as in the intensive therapy group of the DCCT study.33 It would be important to know the effect of control of diabetes during the first years of the disease on the development of shoulder capsulitis.
The correlation between limited joint mobility and microvascular complications of diabetes has been well documented,2022 but there are also two studies showing an association between shoulder capsulitis and retinopathy.'9 21 Our study also showed an association between shoulder capsulitis and proliferative retinopathy in type I patients, but the correlation was fully explained by age and by the duration of diabetes. This indicates that diabetic subjects with shoulder capsulitis do not have a higher risk of microvascular complications, such as limited joint mobility, than those without the condition.
In some patients shoulder capsulitis may precede, accompany, or follow diffuse swelling, coldness, erythema, tenderness, and hyperhidrosis of the hand.4 After weeks or months, the tenderness, swelling, and vasomotor dysfunction completely resolve, with residual atrophic or dystrophic changes, finger contractures, and occasionally shoulder capsulitis. This has been called shoulder-hand syndrome or reflex sympathetic dystrophy. Because of a possible association between reflex sympathetic dystrophy and shoulder capsulitis, autonomic neuropathy may help us to understand the pathogenesis of shoulder capsulitis as previously discussed by Steinbrocker and
Thompson."34 Our study supports this, because we observed about a fourfold and a threefold risk of autonomic neuropathy in type I and II diabetic subjects with shoulder capsulitis, respectively, compared to those without shoulder capsulitis when the confounding effects of age and duration of diabetes were controlled for. A subsample of 121 type I diabetic patients also showed that shoulder capsulitis was associated with impaired heart rate variation, but this association was fully explained by the time related variables. The association between shoulder capsulitis and autonomic neuropathy seen in the present study must be interpreted with care, because our criteria for autonomic neuropathy were "soft" and the heart rate variation test or other neurophysiological testing were not performed in all subjects.
Many investigators have shown a higher prevalence of shoulder capsulitis in diabetic patients and in patients with a history of myocardial infarction.614 On the other hand, diabetes is associated with higher rates of cardiovascular disease.'5 Previously Johnson has suggested that vasoconstriction of the peripheral arteries of the hand resulting from cardiac pain, pre-existing arteriosclerotic narrowing of the vessels of the hands, and anoxia of varying duration and intensity resulting from the myocardial infarction were responsible for the production of local changes in the hands and fingers.'6 Mavrikakis et al have shown that diabetic subjects with shoulder capsulitis had higher cholesterol and triglyceride levels than diabetic subjects without shoulder capsulitis or shoulder capsulitis control group.'6 These results suggest that the higher prevalence of shoulder capsulitis in diabetic patients could be explained by atherosclerotic changes in vessels, leading to changes in local blood flow and producing altered physiology in tendons, with resultant shoulder capsulitis. We studied clinical features which could help us to understand the possible pathogenic associations between shoulder capsulitis, diabetes, and myocardial infarction. Type I diabetic patients with shoulder capsulitis seemed more frequently to have had a history of myocardial infarction than those without shoulder capsulitis, independent of the age of the patient, the duration of their diabetes, hypertension, or smoking habits. The limited number of type I diabetic subjects with a history of myocardial infarction in the present study does not allow us to draw final conclusions, but our data suggest an increase in the prevalence of shoulder capsulitis in patients with a history of myocardial infarction. An association between myocardial infarction and shoulder capsulitis in type II diabetic patients was fully explained by the time related factors. Thus the correlation between shoulder capsulitis and myocardial infarction does not explain the high prevalence of shoulder capsulitis in type II diabetic patients.
Shoulder capsulitis was associated with Dupuytren disease in type I and with limited joint mobility in type II diabetic patients in the present study. Because Dupuytren disease and limited joint mobility were strongly related to the age and duration of diabetes, it is important to control for this confounding effect. After using a stepwise logistic regression analysis, the correlations between shoulder capsulitis and Dupuytren disease and limited joint mobility disappeared. Fisher et al showed an association between shoulder capsulitis and limited joint mobility in 57 diabetic patients. ' '5 18 In conclusion, this study shows that shoulder capsulitis is a common disorder in type I and II diabetic patients. It is associated with age in type I and II diabetic patients and with the duration of diabetes in type I patients, which explains most of its correlations with diabetic complications. Independent associations were found between shoulder capsulitis and autonomic neuropathy in type I and II diabetic subjects and with the history of myocardial infarction in tpe I only.
